A LinkedIn post from Vektor Medical Inc highlights the company’s participation in an upcoming Rhythm Theater session at HRS 2026, focused on non-invasive ECG localization in cardiac electrophysiology. The session, scheduled for Saturday, April 25, features several physicians discussing how pre‑ and intra‑procedural insights can support case planning, procedural efficiency, and targeted mapping and ablation across various arrhythmias.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post also directs attendees to visit adjacent booths to see the company’s vMap technology demonstrated on site. For investors, this presence at a major specialty conference suggests ongoing efforts to drive clinical adoption, gather real‑world feedback, and position vMap within electrophysiology workflows, which could be important for future commercialization, partnership opportunities, and longer‑term revenue growth if clinical interest translates into broader usage.